140 related articles for article (PubMed ID: 12110340)
1. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.
Ramírez-Amador V; Esquivel-Pedraza L; Lozada-Nur F; De la Rosa-García E; Volkow-Fernández P; Súchil-Bernal L; Mohar A
Oral Oncol; 2002 Jul; 38(5):460-7. PubMed ID: 12110340
[TBL] [Abstract][Full Text] [Related]
2. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
McCormick SU
J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
[TBL] [Abstract][Full Text] [Related]
3. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
[TBL] [Abstract][Full Text] [Related]
4. Intralesional vinblastine for treating AIDS-associated Kaposi's sarcoma of the oropharynx and larynx.
Friedman M; Venkatesan TK; Caldarelli DD
Ann Otol Rhinol Laryngol; 1996 Apr; 105(4):272-4. PubMed ID: 8604887
[TBL] [Abstract][Full Text] [Related]
5. Intralesional 3% sodium tetradecyl sulfate for treatment of cutaneous Kaposi's sarcoma.
Kim JY; Kim JS; Kim MH; Park BC; Hong SP
Yonsei Med J; 2015 Jan; 56(1):307-8. PubMed ID: 25510781
[No Abstract] [Full Text] [Related]
6. Intralesional vinblastine in the treatment of oral Kaposi's sarcoma.
Moyle G; Youle M; Barton S
Br J Clin Pract; 1993; 47(2):79-80. PubMed ID: 8334068
[TBL] [Abstract][Full Text] [Related]
7. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
Flaitz CM; Nichols CM; Hicks MJ
Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
[TBL] [Abstract][Full Text] [Related]
8. Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients.
Vassallo C; Carugno A; Derlino F; Ciocca O; Brazzelli V; Borroni G
Cutis; 2015 May; 95(5):E28-34. PubMed ID: 26057517
[TBL] [Abstract][Full Text] [Related]
9. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-Terán G
Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
[TBL] [Abstract][Full Text] [Related]
10. Treating Kaposi's lesions in the HIV-infected patient.
Nichols CM; Flaitz CM; Hicks MJ
J Am Dent Assoc; 1993 Nov; 124(11):78-84. PubMed ID: 8227776
[TBL] [Abstract][Full Text] [Related]
11. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
Epstein JB
Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
[TBL] [Abstract][Full Text] [Related]
12. Intralesional vinblastine for oral Kaposi sarcoma in HIV infection.
Epstein JB; Scully C
Lancet; 1989 Nov; 2(8671):1100-1. PubMed ID: 2572822
[No Abstract] [Full Text] [Related]
13. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
Zidan J; Robenstein W; Abzah A; Taman S
Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
[TBL] [Abstract][Full Text] [Related]
15. Management of oral lesions in HIV-positive patients.
Baccaglini L; Atkinson JC; Patton LL; Glick M; Ficarra G; Peterson DE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S50.e1-23. PubMed ID: 17379155
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Turiansky G; Wagner KF
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
[TBL] [Abstract][Full Text] [Related]
17. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
[TBL] [Abstract][Full Text] [Related]
18. Management of oral Kaposi's sarcoma and a proposal for clinical staging.
Epstein JB
Oral Dis; 1997 May; 3 Suppl 1():S124-8. PubMed ID: 9456673
[TBL] [Abstract][Full Text] [Related]
19. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
[TBL] [Abstract][Full Text] [Related]
20. Intralesional bleomycin and sodium tetradecyl sulphate for haemangiomas and lymphangiomas.
Harjai MM; Jha M
Afr J Paediatr Surg; 2012; 9(1):47-51. PubMed ID: 22382104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
